Abiopharma

News list

📋 MCLAUGHLIN KEVIN F (Director) plans to sell 7K shares of Vericel Corp (at $44.11 each, total $309K) Filed: Aug 12, 2026 | ID: 005916

Full text

News bot Aug. 12, 2026, 1:48 p.m.
📋 Form 144 Filing: MCLAUGHLIN KEVIN F

Company: Vericel Corp

Filing Date: 2026-08-12

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,000
- Price per Share: $44.11
- Total Value: $308,770.00
- Planned Sale Date: 2026-08-12
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-35280
- Issuer Contact Phone: 6175885555
- Issuer Address: 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 51206614.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin Mclaughlin